Trelegy Ellipta Inhaler

$50

SKU: Trelegy Ellipta Inhaler Category: Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Trelegy Ellipta Inhaler

What is Trelegy Ellipta Inhaler?

Trelegy Ellipta is a once-daily inhalation powder that combines three active medications:

  • Fluticasone Furoate (an inhaled corticosteroid)
  • Umeclidinium Bromide (a long-acting muscarinic antagonist, LAMA)
  • Vilanterol (a long-acting β₂-agonist, LABA) (GSKpro)

It is used for maintenance treatment in adults with:

  • Chronic Obstructive Pulmonary Disease (COPD) including chronic bronchitis and emphysema. (GSKpro)
  • Asthma (in adults) where additional control is needed. (FDA Access Data)

Important: Trelegy Ellipta Inhaler is not for sudden breathing problems (i.e., not a rescue inhaler). (trelegy.com)


How does it work?

Because it combines three classes of medications, Trelegy Ellipta offers a “triple therapy” effect:

  • The corticosteroid (fluticasone) helps reduce inflammation in the airways. (Mayo Clinic)
  • The muscarinic antagonist (umeclidinium) relaxes airway muscles by blocking certain receptors in airway smooth muscle. (European Medicines Agency (EMA))
  • The β₂-agonist (vilanterol) also opens airways by stimulating β₂ receptors in airway smooth muscle. (European Medicines Agency (EMA))

Together, they help improve breathing, reduce exacerbations (flare-ups) and maintain better lung function in patients whose symptoms are not adequately controlled by dual therapy. (European Medicines Agency (EMA))


Who is it for & how is it used?

Who:

  • Adults with COPD whose disease is not sufficiently controlled with other inhaled medications. (trelegy.com)
  • Adults with asthma (18 yrs+), as a maintenance therapy. (WebMD)
  • Not for children under 18 (safety and efficacy have not been established). (trelegy.com)

How to use (basic steps):

  • It’s inhalation powder, once daily. (GSKpro)
  • The inhaler device should be used exactly as instructed:
    • Open the cover, slide it down until you hear a click.
    • Breathe out fully (but not into the mouthpiece).
    • Place the mouthpiece in your mouth, close lips, and take a long, steady, deep breath in. (trelegyhcp.com)
    • Hold your breath for ~3‐4 seconds (or as long as comfortable). (trelegyhcp.com)
    • Remove the inhaler and breathe out slowly.
    • Rinse your mouth with water after use and spit out (to reduce risk of oral thrush). (WebMD)

Benefits of Trelegy Ellipta Inhaler

  • One inhaler, one dose per day: convenience and likely better adherence.
  • Provides triple therapy (ICS + LAMA + LABA) in a single device, which may simplify treatment in patients previously on multiple inhalers.
  • Clinical data (EU summary) show that compared with dual therapy in some studies: fewer exacerbations, better lung-function improvement. (European Medicines Agency (EMA))
  • Because it addresses multiple pathways (inflammation + airway narrowing + airway muscle tone), it can be more effective for certain patients whose COPD/asthma remains uncontrolled.

Risks & Side Effects

As with all medications, there are potential side-effects and safety considerations. Some key ones:

Common side effects:

  • Upper respiratory tract infection, throat issues, cough. (GSKpro)
  • Oral candidiasis (thrush) — hence the post-use mouth rinsing. (WebMD)

Serious or important risks / warnings:

  • Pneumonia risk increased in COPD patients using inhaled corticosteroids. (GSKpro)
  • Not for acute bronchospasm or sudden attacks. (trelegy.com)
  • Contains a LABA (vilanterol) – in asthma when LABA are used alone there is increased risk of asthma-related death. Although Trelegy uses it in combination, the warning remains. (trelegyhcp.com)
  • Use with caution in patients with heart problems, high blood pressure, arrhythmias, active infection, glaucoma or cataracts, urinary retention, etc. (FDA Access Data)
  • Do not use if allergic to milk proteins (some inhaler excipient). (trelegy.com)

Practical Tips & Things to Ask Your Doctor

  • Make sure you have a reliable rescue inhaler (short-acting bronchodilator) for sudden attacks; Trelegy Ellipta is not for immediate relief.
  • Verify your inhaler technique: even the best device won’t help if you’re using it incorrectly. Ask a healthcare professional to demonstrate.
  • Monitor for any changes: more frequent exacerbations, worsening cough, mucus changes, side-effects like hoarseness or thrush.
  • Keep track of your inhaler dose-counter and know when you need a refill.
  • Ask if your insurance covers this inhaler and whether any prior authorization is needed.
  • Ask about cost-saving programs: some manufacturers offer savings or caps on out-of-pocket for eligible patients.
  • If you smoke: quitting smoking remains a major part of managing COPD/asthma even with inhaler therapy.
  • If you have other conditions (heart disease, glaucoma, osteoporosis, diabetes), inform your doctor as these may affect treatment choice.

Summary

Trelegy Ellipta is a convenient, once-daily triple-therapy inhaler for adults with COPD or asthma needing a higher level of maintenance control. Its strength lies in combining three mechanisms to tackle airway inflammation, muscle constriction, and airway narrowing. However, like all medicines, it comes with risks and is not a substitute for a rescue inhaler in acute situations. Proper inhaler technique, cost/access considerations, and ongoing monitoring are key for optimal benefit.

Website : Jyotilifecar